Interferon gamma Regulation of CD4 T Cell Responses in Tuberculosis

干扰素 γ 对结核病中 CD4 T 细胞反应的调节

基本信息

  • 批准号:
    7541020
  • 负责人:
  • 金额:
    $ 4.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tuberculosis is a major public health problem. The causative agent of tuberculosis, Mycobacterium tuberculosis (Mtb), currently infects nearly one third of the human population and causes over 2 million deaths annually. For reasons that are not yet fully understood, the immune system fails to completely clear the infection, which persists in macrophages. The broad objective of this proposal is to elucidate mechanisms regulating immunity during tuberculosis. Control of Mtb infection is attributed to T helper type 1 CD4 T cells which secrete interferon gamma (IFNg). IFNg activates macrophages inducing the production of reactive nitrogen and oxygen intermediates which, in turn, limit bacterial replication and dissemination. IFNg has regulatory effects on many other cell types as well. While CD4 T cells and IFNg are both abundant in the lungs during tuberculosis, we currently do not know if and how IFNg regulates CD4 T cell responses during this infection. Using a well-established mouse model of tuberculosis we will test the hypothesis that IFNg acts directly on CD4 T cells to regulate their differentiation, function and turnover during Mtb infection. We will compare Mtb-specific CD4 T cells that do or do not express a functional IFNg receptor. This approach will allow us to address the direct effects of IFNg on CD4 T cells in an otherwise normal host environment (ie: all other cell types express a functional IFNg receptor). In Aim 1 we will analyze expansion and differentiation of wild type and IFNg receptor-deficient Mtb-specific CD4 T cells in the lungs and relevant lymphoid tissues of Mtb infected mice. Aim 2 will address whether IFNg promotes contraction and/or turnover of CD4 T cells during Mtb infection. In Aim 3 we will address the direct effects of IFNg on CD4 T cells at the molecular level. PUBLIC HEALTH RELEVANCE: The emergence of antibiotic-resistant strains of Mtb, the lack of an effective vaccine and the growing population of immunosuppressed patients (largely due to HIV-infection) contribute to the tuberculosis crisis. It is well-established that IFNg is an essential cytokine that controls Mtb infection, and that CD4 T cells are critical for secreting IFNg. However, our current knowledge of how IFNg contributes to CD4 T cell function is inadequate. Thus, an understanding of the role of IFNg in shaping CD4 T cell differentiation and function is critical for a complete picture of how protective CD4 T cell immunity is established and maintained during Mtb infection.
描述(由申请人提供):结核病是一个重大的公共卫生问题。结核病的病原体结核分枝杆菌目前感染了近三分之一的人口,每年造成200多万人死亡。由于尚未完全了解的原因,免疫系统无法完全清除感染,这种感染持续存在于巨噬细胞中。本提案的主要目的是阐明结核病期间调节免疫的机制。结核分枝杆菌感染的控制归因于分泌干扰素γ (IFNg)的T辅助型1 CD4 T细胞。IFNg激活巨噬细胞,诱导活性氮和氧中间体的产生,从而限制细菌的复制和传播。IFNg对许多其他类型的细胞也有调节作用。虽然在结核病期间,CD4 T细胞和IFNg在肺部都很丰富,但我们目前尚不清楚IFNg是否以及如何调节这种感染期间的CD4 T细胞反应。利用一种成熟的小鼠结核病模型,我们将验证IFNg直接作用于CD4 T细胞以调节其在结核分枝杆菌感染期间的分化、功能和转换的假设。我们将比较mtb特异性CD4 T细胞是否表达功能性IFNg受体。这种方法将使我们能够在正常宿主环境(即所有其他细胞类型表达功能性IFNg受体)中解决IFNg对CD4 T细胞的直接影响。在Aim 1中,我们将分析野生型和IFNg受体缺陷型Mtb特异性CD4 T细胞在Mtb感染小鼠肺部和相关淋巴组织中的扩增和分化。目的2将探讨IFNg是否促进Mtb感染期间CD4 T细胞的收缩和/或周转。在目标3中,我们将在分子水平上讨论IFNg对CD4 T细胞的直接影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATHERINE C. MACNAMARA其他文献

KATHERINE C. MACNAMARA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATHERINE C. MACNAMARA', 18)}}的其他基金

Improving Inflammation Resolution to Mitigate Acquired Bone Marrow Failure
改善炎症消退以减轻获得性骨髓衰竭
  • 批准号:
    10595109
  • 财政年份:
    2023
  • 资助金额:
    $ 4.96万
  • 项目类别:
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection
严重感染时造血干细胞功能障碍和再生
  • 批准号:
    10371061
  • 财政年份:
    2019
  • 资助金额:
    $ 4.96万
  • 项目类别:
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection
严重感染时造血干细胞功能障碍和再生
  • 批准号:
    9902469
  • 财政年份:
    2019
  • 资助金额:
    $ 4.96万
  • 项目类别:
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection
严重感染时造血干细胞功能障碍和再生
  • 批准号:
    10598451
  • 财政年份:
    2019
  • 资助金额:
    $ 4.96万
  • 项目类别:
HSC function during infection
感染期间HSC的功能
  • 批准号:
    8689208
  • 财政年份:
    2014
  • 资助金额:
    $ 4.96万
  • 项目类别:
Interferon gamma Regulation of CD4 T Cell Responses in Tuberculosis
干扰素 γ 对结核病中 CD4 T 细胞反应的调节
  • 批准号:
    7666156
  • 财政年份:
    2008
  • 资助金额:
    $ 4.96万
  • 项目类别:

相似海外基金

AEROSOLS
气雾剂
  • 批准号:
    10101317
  • 财政年份:
    2024
  • 资助金额:
    $ 4.96万
  • 项目类别:
    EU-Funded
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
  • 批准号:
    10092043
  • 财政年份:
    2024
  • 资助金额:
    $ 4.96万
  • 项目类别:
    EU-Funded
Molecular-level Understanding Of Atmospheric Aerosols (MUOAA 2024); Corsica, France; April 1-5, 2024
对大气气溶胶的分子水平理解(MUOAA 2024);
  • 批准号:
    2332007
  • 财政年份:
    2024
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Standard Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
  • 批准号:
    NE/Y000021/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Research Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
  • 批准号:
    NE/Y000358/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Research Grant
Southern Ocean aerosols: sources, sinks and impact on cloud properties
南大洋气溶胶:来源、汇以及对云特性的影响
  • 批准号:
    DP240100389
  • 财政年份:
    2024
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Discovery Projects
An AI-driven clinical washbasin unit that automatically disinfects pathogens, reduces aerosols and decreases healthcare-acquired infections by 70%
%20人工智能驱动%20临床%20洗脸盆%20单位%20%20自动%20消毒%20病原体,%20减少%20气溶胶%20和%20减少%20医疗保健获得性%20感染%20by%2070%
  • 批准号:
    83001507
  • 财政年份:
    2023
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Innovation Loans
Cloudbusting with JWST: characterising aerosols, aurorae and chemistry in substellar atmospheresto the water cloud regime
使用 JWST 进行云消除:描述水云状态下恒星大气中的气溶胶、极光和化学成分
  • 批准号:
    ST/X001091/1
  • 财政年份:
    2023
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Research Grant
INvestigating Home water and Aerosols' Links to opportunistic pathogen Exposure (INHALE): do consumer decisions impact pathogen exposure and virulence?
调查家庭用水和气溶胶与机会性病原体暴露(吸入)的联系:消费者的决定是否会影响病原体暴露和毒力?
  • 批准号:
    2326096
  • 财政年份:
    2023
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Standard Grant
Bioactivated Aerosols for Combustion Product Capture
用于燃烧产物捕获的生物活性气溶胶
  • 批准号:
    10080253
  • 财政年份:
    2023
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Small Business Research Initiative
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了